Skip to Main Content
Diseases of the Digestive System - Liver | Pregnancy, Childbirth and the Puerperium, Phase 2a/2b

A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)

What is the purpose of this trial?

The purpose of this clinical research study is to evaluate the efficacy, safety and tolerability of the study medicine, volixibat, in patients with Intrahepatic cholestasis of pregnancy (ICP) and elevated serum bile acid concentrations.

  • Trial with
    Mirum Pharmaceuticals Inc.
  • Ages
    18 years - 45 years
  • Gender
    Female only

Contact Information

For more information about this study, including how to volunteer, contact Lauren Perley

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    04/09/2024
  • Study HIC
    #2000029456